Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abbreviated, advisory, amortizable, ANDA, API, approaching, Asubio, Bel, Berger, bioequivalence, Boulevard, bound, bryan, buyout, carcinogenicity, carryforward, caution, centralized, chemistry, cited, clarification, commented, compound, conclusive, cycle, DC, decentralized, deferral, discovered, disorder, dispense, dispersed, disregarded, dissolved, division, dosage, DTC, easily, encoding, England, Eric, ESRD, exemption, FDAAA, FDC, foot, frame, Frameworkissued, France, GCP, Germany, graph, halted, headcount, healthy, HPA, hyperphenylalaninemia, iga, IGAN, incremental, IND, inInternal, instance, internet, IRB, irrespective, Istanbul, iv, judicial, jurisdiction, KGaA, kidney, lab, language, leverage, literature, MAA, Marin, mg, MMS, mortgage, NA, Naglayzme, NE, nephropathy, newly, nonfinancial, novelty, nucleic, objective, Orange, outline, overlap, owed, path, Paulo, pharmacological, pharmacology, postmarket, PREA, prevail, protease, protocol, questioned, reauthorized, reconsider, recordkeeping, referenced, refusal, reinvested, reinvestment, renal, representational, reproductive, restructured, restructuring, resubmission, Sankyo, Sao, satisfaction, Sciele, send, sequential, shown, sickle, Similarly, site, sought, stalled, Street, subpopulation, subprime, successfullydevelop, surveillance, taxation, temporarily, territory, tiered, toxicity, Turkey, Twenty, unacceptable, unannounced, undertaken, undisclosed, undistributed, unusual, vector, vigorously, visiting, waiting, warning, Women, Wood
Removed:
aging, anticipation, bulk, chain, check, CIBC, circumstance, classic, codify, Commencing, customary, decade, delinquent, demonstrated, Drapeau, eat, eliminating, enable, enroll, enrolled, escrow, essentially, exceeded, expediting, FAS, favor, filer, guaranteed, immaterial, injectable, Kendle, lead, leading, lender, met, mild, moderate, municipal, overstocking, par, PDUFA, pharmacy, Phenoptin, placebo, preceding, predetermined, preliminary, project, promissory, recovered, recurring, regional, Rule, seller, serve, Shiratori, sophisticated, spot, succeeding, terminable, timeframe, tolerability, UBS, unrestricted, utilization, validate
Filing tables
Filing exhibits
- 10-K Annual report
- 10.30 Manufacturing, Marketing and Sales Agreement
- 10.31 Amended and Restated Collaboration Agreement
- 10.32 Members Agreement
- 21.1 Subsidiaries of Biomarin
- 23.1 Consent of KPMG LLP
- 23.2 Consent of Pricewaterhousecoopers, LLP
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32.1 Certification of Chief Executive Officer and Chief Financial Officer
- 99.1 Biomarin/genzyme LLC Consolidated Financial Statements
Related press release
BMRN similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-132566) and Form S-8 (Nos. 333-136963, 333-85368, 333-84787) of BioMarin Pharmaceutical Inc. of our report dated February 25, 2008 relating to the financial statements of BioMarin/Genzyme LLC, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 25, 2008